ScreenerHero
ONCOOncopeptides AB (publ)
STO · SE · Healthcare · Biotechnology · oncopeptides.com
1.676SEK-3.90%Mkt Cap: 61.14M $P/E: —

Oncopeptides AB (publ), a biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally…

Industry Peers

Biotechnology
Screen all
VX1
Vertex Pharmaceuticals Incorporated
$130.23BUSDP/E 32.1
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
argenx SE
$61.34BUSDP/E 39.8
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5

Key Statistics

Company
Market Cap61.14M $
Enterprise Value59.59M $
Revenue (TTM)7.96M $
Gross Profit6.57M $
Net Income (TTM)-23.87M $
Revenue/Share0.0329 USD
Last Price1.676 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees77
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0009414576
Valuation
P/E (Trailing)—
P/E (Forward)-2.43
PEG—
EV/EBITDA-3.10
EV/Revenue7.49
P/S7.89
P/B8.88
EPS (TTM)-0.87
EPS (Forward)-0.71
52W Range
1.2658% of range6.550
52W High6.550 SEK
52W Low1.265 SEK
Profitability
Gross Margin96.55%
Oper. Margin-147.85%
EBITDA Margin-241.61%
Profit Margin-350.94%
ROE423.81%
ROA-184.33%
Growth
Revenue Growth91.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-21.32M $
CapEx (TTM)—
FCF Margin-144.30%
FCF Yield-18.79%
Net Debt-6.35M $
Net Debt/EBITDA0.33
Balance Sheet
Debt/Equity-2.37
Current Ratio4.55
Quick Ratio4.38
Book Value/Sh0.1940 SEK
Cash/Share0.5190 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)2.500 SEK
Upside (mean)+49.2%
Target Range2.100 SEK – 3.100 SEK
SEK2.100+49.2% to meanSEK3.100
# Analysts3
Ownership
Shares Out.381.36M
Float379.18M
Insiders3.85%
Institutions14.37%
Technical
SMA 501.626 (+3.1%)
SMA 2002.546 (-34.2%)
Beta-1.33
S&P 52W Chg18.16%
Avg Vol (30d)1.58M
Avg Vol (10d)2.36M
Technical Indicators
RSI (14)65.3
MACD0.0232
MACD Signal0.0033
MACD Hist.+0.0199
BB Upper1.736 SEK
BB Middle1.621 SEK
BB Lower1.507 SEK
BB Width14.13%
ATR (14)0.0683 SEK
Vol Ratio (20d)1.90x